awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36118178-2CA3C68C-3EAF-45C1-8C28-1C45C91E32A2
Q36118178-2CA3C68C-3EAF-45C1-8C28-1C45C91E32A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36118178-2CA3C68C-3EAF-45C1-8C28-1C45C91E32A2
Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
P2860
Q36118178-2CA3C68C-3EAF-45C1-8C28-1C45C91E32A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36118178-2CA3C68C-3EAF-45C1-8C28-1C45C91E32A2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
767417bc5e6b42487770bdd4b92d4f455a0aafef
P2860
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.